Smoking cessation support less likely for cancer patients

October 4, 2017

(HealthDay)—General practitioners are less likely to support cessation of smoking in patients with cancer than in those with coronary heart disease (CHD), according to a study published online Sept. 11 in the Annals of Family Medicine.

Amanda Farley, Ph.D., from the University of Birmingham in the United Kingdom, and colleagues used electronic primary care records to match 12,393 patients with incident cases of cancer diagnosed from 1999 to 2013 with incident cases of CHD diagnosed during the same period in a 1-to-1 ratio.

The researchers found that 32 and 18.2 percent of patients with cancer and CHD smoked tobacco at diagnosis. Compared to patients with CHD, patients with cancer were less likely to have their general practitioner update their , advise quitting, or prescribe medication (odds ratios, 0.18, 0.38, and 0.67, respectively); they were also less likely to have stopped smoking (odds ratio, 0.76). One year later, 61.7 and 55.4 percent of patients with cancer and CHD, respectively, who had smoked at diagnosis were still smoking. Introducing incentive payment correlated with more frequent interventions, though not for patients with CHD specifically.

"General practitioners were less likely to support in patients with cancer than with CHD, and with were less likely to stop smoking," the authors write.

Explore further: Cancer patients receive less support to quit smoking than patients with heart disease

More information: Abstract
Full Text

Related Stories

Cancer patients receive less support to quit smoking than patients with heart disease

September 12, 2017
Although a cancer diagnosis can motivate people to try to quit smoking, a study of British general practitioners finds that physicians are more likely to support smoking cessation in primary care patients with coronary heart ...

Cancer survivors who quit smoking sooner can live longer

September 12, 2017
Lung cancer survivors who quit smoking within a year of diagnosis will live for longer than those who continue to smoke, according to new research led by the Universities of Birmingham and Oxford.

Pre-cosmetic Sx advice may aid long-term smoking cessation

September 7, 2017
(HealthDay)—Asking patients to stop smoking before undergoing cosmetic surgery can promote long-term smoking cessation, according to a study published in the September issue of Plastic and Reconstructive Surgery.

Smoking negatively impacts long-term survival after breast cancer

September 21, 2017
A new study published in JNCI Cancer Spectrum finds that smoking negatively impacts long-term survival after breast cancer. Quitting smoking after diagnosis may reduce the risk of dying from breast cancer.

Cancer risk up for RA patients with venous thromboembolism

September 27, 2017
(HealthDay)—Patients with rheumatoid arthritis (RA) and venous thromboembolism (VTE) have increased risk of cancer in the first year after VTE and during a longer follow-up period, according to a study published online ...

Occult cancer found in ~5 percent with unprovoked VTE

August 23, 2017
(HealthDay)—About one in 20 patients with unprovoked venous thromboembolism (VTE) have occult cancer detected within one year, according to a review published online Aug. 22 in the Annals of Internal Medicine.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.